Background: Occipital nerve stimulation (ONS) has been used for the treatment of neuropathic pain conditions and could be a therapeutic approach for refractory cervicogenic headache (CeH).
Aim: The aim of this study is to assess the efficacy and safety of unilateral ONS in patients suffering from refractory CeH.
Methods: We conducted a retrospective chart review on patients implanted from 2011 to 2013 at CHUM.